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Abstract 
Objectives: To identify characteristics of patients who accepted or declined an appointment for a transition of care service provided by 
an independent community pharmacist and identify the most common reasons patients declined the service. 
Methods: A transition of care service was offered by a community pharmacy to patients discharged to home from the cardiac unit of 
a local hospital. The community pharmacist approached patients prior to discharge for recruitment into the service. Outcomes included 
service acceptance rate, LACE score at discharge, readmission risk category, age, gender, geographic home location, and reason for 
refusing the service. Descriptive statistics and logistic regression were used to compare characteristics between those who accepted or 
declined the service. Reasons for decline were assessed using content analysis. 
Results: Of the 87 patients that were included in the analysis, 21 patients received the transitions of care service (24.1%). None of the 
characteristics were found to be statistically significant between patients who received or declined the service. Patients at a moderate 
risk for readmission seemed more likely to accept the pharmacist-run appointment than those at high risk (27.9% vs 15.3%; P = 0.29). 
Of the 66 patients who declined, 51 gave a reason (77.3%). Thirty-nine patients saw no benefit (76.5%), five patients had perceived 
barriers (10%), and seven patients gave reasons that fell into both categories (13.5%). 
Conclusions: This evaluation did not find a statistically significant difference in characteristics between those patients who accepted or 
declined participation in a pharmacist-run transition of care service. Patients may be less likely to accept pharmacist-run transition of 
care appointments primarily due to no perceived benefits. To increase participation, we need to understand the patient’s health beliefs, 
educate patients on pharmacy services, and implement changes to recruit potential patients. 
 
 
Background 
The transition from hospital to home can be a confusing time 
for patients.1-2 Many patients are given changes in their 
medications or new prescriptions resulting in an increased risk 
for medication errors and adverse events. Without an 
appropriate follow-up, medication errors and adverse effects 
may not be discovered until a patient presents to the 
emergency room and is readmitted to the hospital.  
 
Pharmacists are uniquely trained and qualified to assess 
indications, duplications, interactions, and adverse effects of 
drugs.3 These skills allow pharmacists to provide unique, 
clinical pharmaceutical care services such as medication 
therapy management (MTM), complete medication 
reconciliation, medication education, and transition of care 
appointments. Pharmacy clinical services incorporating 
medication reviews can help to reduce adverse drug events 
and readmissions. 4-8 For example, in the community setting an 
absolute risk reduction of 13.1% in hospital readmissions  
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was seen for patients participating in a pharmacist-run 
transition of care service.4  
 
Although evidence demonstrates the success of these 
pharmacy-run services, patients are not always eager to 
participate.9 Some evidence suggests that patients may not 
have a clear understanding of the pharmacist’s role or the 
usefulness of clinical pharmacy services such as medication 
reviews.9-12 Even less information exists to identify which types 
of patients may decide to use optional clinical pharmacy 
services; but limited evidence suggests patients with more 
complex conditions are more likely to participate.13 The 
objective of this evaluation was to identify characteristics of 
patients who accept or decline an appointment for a transition 
of care service provided by an independent community 
pharmacist. A secondary objective was to identify the most 
common reasons a patient may decline the service. This 
information can allow pharmacists to strategize ways to 
overcome barriers to patients accepting appointments.  
 
Methods 
This prospective, observational evaluation of patient 
participation in a transition of care service provided by a 
community pharmacist was determined to not fit the federal 
definition of research using the University of Wisconsin-
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Madison research decision tool.14 Patients were not required 
to complete informed consent for the evaluation as this was 
considered a quality improvement project. Streu’s Pharmacy 
Bay Natural, an independent community pharmacy in Green 
Bay, partnered with Bellin Hospital to provide a pilot transition 
of care service for the cardiac unit. Patients were eligible for 
the service if they were a Wisconsin resident on the cardiac 
unit with moderate to high risk for readmission and plans for 
discharge home. Readmission risk was assessed using the LACE 
scoring tool which evaluated the patient’s likelihood of 
readmission using the patient’s length of stay, acuity of care, 
comorbidities, and number of emergency room visits in the 
last six months.15 Patients with a LACE score of 5 or greater 
were eligible for inclusion. Patients were excluded if they were 
discharged to an inpatient rehabilitation or long-term care 
facility. The pharmacist would meet with an available member 
of the nursing staff on the floor prior to approaching patients 
to identify which patients on cardiac unit were eligible for the 
service. The hospital staff did not participate in direct 
recruitment of patients.  
 
Eligible patients were approached only by a single pharmacist, 
the community pharmacy resident, at the hospital during his 
or her stay at any convenient time prior to discharge in order 
to explain and offer the service. While the introduction was 
individualized for each patient and not scripted, the 
introduction generally included informing patients that the 
service was free of charge, explaining that patients did not 
have to get their medications at Streu’s Pharmacy to 
participate, and a brief description of what would occur during 
and after their appointment. During the one-hour 
appointment with the pharmacist, patients had a complete 
medication review, received further education on medical 
conditions and medications, and had a chance to ask questions 
related to their health. Afterwards, a letter was sent to his or 
her provider(s) by the pharmacist with a summary of the 
appointment and any noted concerns. A handout reinforcing 
this information was given to each patient approached about 
participating in the service. If a patient was interested in an 
appointment, the community pharmacist telephoned the 
patient after discharge to schedule an appointment. All 
patients had the option to schedule an appointment at the 
community pharmacy or by phone. Patients living within 
Green Bay or DePere, Wisconsin could schedule appointments 
at their home or at a local Bellin provider’s office. Patients 
living in Wisconsin near Iron Mountain, Algoma, Oconto, and 
Marinette could schedule a telehealth appointment through 
their local Bellin provider offices. Patients who did not show 
up for their appointments were called to reschedule. 
 
The primary outcome of the evaluation was patient 
acceptance of an appointment. In order to determine both the 
characteristics and reasons that increased the likelihood of a 
person declining the pharmacist-run transitions of care 
service, a mixed methods approach of quantitative and 
qualitative analysis was used. The quantitative analysis 
included five characteristics: LACE score at discharge, 
readmission risk category, age, gender, and geographic 
location. A LACE score of 5 to 9 and 10 or greater was defined 
as moderate and high risk for readmission respecively.15 Data 
was collected from a chart review by the community 
pharmacist.  
 
A qualitative analysis evaluated patient reasons for decline. If 
a patient refused the service at any time, he or she was marked 
as declined and was not contacted again. The pharmacist kept 
field notes and immediately recorded any verbal comment 
given as a reason for decline during or directly after the patient 
interaction. Audio recording was not used for collecting 
reasons for decline. Reasons for decline were collected 
throughout the entire evaluation period. If the patient did not 
provide a reason for declining participation, the pharmacist did 
not ask for one. Patients were also marked as decline if they 
were unreachable or did not respond to messages left by the 
pharmacists. Only patients who were scheduled and 
successfully met were marked as accepted.   
 
Descriptive statistics were used to describe the characteristics 
between the patients who accepted and declined the 
transitions of care service. Fisher’s Exact Test, Mann Whitney 
U Test, and logistic regression were used to compare patient 
characteristics between the two groups. A sensitivity analysis 
was done excluding patients who were unreachable and 
marked as declined. 
 
The reasons patients shared for declining the transitions of 
care service were assessed utilizing content analysis. Two 
investigators participated in reviewing the documented 
comments. After an initial review, the first investigator (ARM) 
recognized two themes from The Health Belief Model: no 
perceived benefit and perceived barrier. Patients were coded 
into one or both of these constructs by the second investigator 
(JMK) prior to a final review of the coding by the first 
investigator.   
 
Results 
Data was collected over a 6-month period during September 
2015 and January 2016. Eligible patients were identified to the 
pharmacy resident by the nursing staff available on the days 
the pharmacist went to the hospital to recruit. However, some 
eligible patients were not available to meet with the 
pharmacist during the recruitment time as they were asleep or 
out of the room for imaging or procedures. Of the 114 patients 
identified as eligible, 87 patients were approached and 
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included in the analysis: 21 patients participated in the 
transitions of care service (24.1%), 56 patients declined 
(64.4%), and 10 patients were not reached and marked as 
declined (11.5%) (See Figure 1). Of the 87 patients included in 
analysis, the majority were at moderate risk for readmission 
(70.1%) with an average LACE score of 8.7±2.4 points. LACE 
scores ranged from 5 to 16 points across all eligible patients 
(See Table 1).  
 
There were no statistically significant differences in the 
characteristics between the 66 patients who declined and the 
21 patients who accepted for any characteristics (See Table 1 
and Table 2). When assessing readmission risk in this 
evaluation, it was found that moderate risk patients may be 
more likely to accept than those at high risk (27.9% vs 15.3%; 
P = 0.29). When evaluating the average LACE scores, a one 
point increase (higher readmission risk) can be seen in the 
average LACE score for those who declined versus those who 
accepted (8.9 points vs 7.9 points; P = 0.09). The logistic 
regression yielded similar results; for a one-point increase in 
LACE score, a patient was less likely to accept an appointment 
(OR 0.79 [95%CI, 0.61 – 1.02]; P = 0.065). The sensitivity 
analysis without patients who were not reached was 
consistent with the primary analysis. 
 
Of the 66 patients who declined, 51 patients (77.3%) gave a 
reason for decline, 5 patients (7.5%) gave no reason, and 10 
patients (15.2%) were not reached. When performing content 
analysis, two constructs of the health belief model stood out: 
no perceived benefit and perceived barriers. All reasons for 
decline fell into one or both of these categories; there were no 
negative cases. Examples of no perceived benefit included “my 
doctor takes care of everything” and “I have been on the same 
medications for years”. Perceived barriers often had to do with 
the patient citing a busy schedule such as “I have too many 
doctor appointments right now”. Of the 51 patients who gave 
reasons for decline, 39 patients saw no benefit (76.5%), 5 
patients had perceived barriers (10%), and 7 patients gave 
reasons that fell into both categories (13.5%).  
 
 
Discussion 
Patients at a moderate risk for readmission appear more likely 
to accept pharmacist-run transition of care appointments than 
patients at a high risk for readmission. This finding conflicts 
with previous research where patients with diabetes at a 
higher risk for complications and more complex regimens used 
pharmacist-run MTM appointments more frequently than 
patients at lower risk for complications.13 By including a 
qualitative approach, this evaluation can begin to describe why 
these finding differ. While it was expected those at a higher 
risk for readmission would seek additional services to prevent 
readmission, it appears those individuals felt they already had 
comparable services in place. 
 
The majority of patients who declined the pharmacist-
provided transition of care appointment did not see a benefit 
to participating in the additional service. A study of patient 
perceptions and interest in a pharmacist-provided MTM 
service found patients were more willing to participate when 
they had high expectations of increased knowledge, improved 
medication management capability, and decreased 
medication concerns.12 However, most patients had low 
expectations regarding the extent of benefits to be gained. 
Evaluations have also demonstrated that when patients lack 
an understanding of the pharmacist’s role, patients are less 
likely to pursue interactions with the pharmacist.10-11 In these 
situations, providing patient education about the pharmacist’s 
role improved and increased patient-pharmacist engagement. 
Marketing clinical pharmacy services can be a challenging task. 
However, if pharmacists are to be seen as providers, patients 
need to understand what it is that the pharmacists can 
provide. Pharmacists are medication experts who can provide 
in-depth drug education, monitoring for interactions and 
adverse effects, and patient-centered drug therapy 
recommendations.3 For those who see little benefit, the 
uniqueness and value of the clinical pharmacy service needs to 
be explained. Patients may be more willing to participate when 
they understand that the benefits offered by pharmacy 
services are unique and cannot be similarly obtained through 
visits with other health care providers.16 By sharing 
information through pamphlets, on-on-one discussions, or 
group classes, pharmacists can work to clarify 
misunderstandings and try to increase acceptance rates for 
clinical pharmacy services. 
 
Pharmacists would also benefit from having an increased 
awareness of how their patients view their own healthcare 
situations. The Health Belief Model was developed to predict 
health behaviors by assessing the attitudes and beliefs of 
patients regarding their health.17 During content analysis two 
constructs of The Health Belief Model were identified: no 
perceived benefits and perceived barriers. By knowing the 
population being targeted, pharmacists can adjust the 
advertising and recruitment procedures as necessary. In order 
to capture as many patients as possible, it is important to tailor 
the message separately for those likely to accept versus those 
likely to decline. In this case among patients declined the 
service, the reason was often no perceived benefit, they felt 
they already had the service through other healthcare 
professionals. The message should be adjusted based on the 
reason for declining, in this case by explaining how a 
pharmacist-run appointment can compliment their physician 
or other resources. 
Original Research PRACTICE-BASED RESEARCH 
 
http://z.umn.edu/INNOVATIONS                         2017, Vol. 8, No. 1, Article 16                        INNOVATIONS in pharmacy   4 
 
 
Modifications to the recruitment protocol may help to 
increase patient participation. In this evaluation, the service 
was introduced to the patient as an optional appointment by 
a non-hospital staff member on select days. It may have been 
more efficient and effective to have a hospital staff member 
discuss the service with every patient prior to discharge. When 
other healthcare team members endorse clinical pharmacy 
services, patient acceptance rates increase.16,18 The pharmacy 
would be responsible for providing literature, such as a 
pamphlet, to explain the uniqueness and value of the clinical 
pharmacy service in order to increase perceived benefit for the 
patients. The discharge staff could provide a brief explanation 
of the service, distribute the literature, and schedule the 
appointment at bedside if accepted by the patient. 
 
There were several limitations to this evaluation. One 
pharmacist completed recruitment, and when the pharmacist 
had competing obligations, patients were not offered the 
service. Since patients were only offered appointments when 
the pharmacist was available, the time between the 
pharmacist visit and discharge was not uniform. During the 
time between the pharmacist’s visit and when the pharmacist 
called the patients after discharge, patients may have changed 
their mind about participating. There were also 3 cases where 
patients who were initially eligible during the pharmacists visit 
but were later discharged to an inpatient facility and no longer 
eligible. As a result, this evaluation had a small sample size 
which limited the power of the analysis. Modifying the 
recruitment protocol may help to overcome this obstacle as 
well as training additional pharmacists to help run the service. 
Additionally, this evaluation was not designed to assess other 
characteristics that may have affected patient decisions such 
as health beliefs, health literacy, and accessibility to other 
health services. For example, patients with established 
primary care and/or specialty cardiology services may have 
been less likely to accept the service, however, this data was 
not available in this evaluation. While other reasons for 
declining the pharmacist-run transition of care service may not 
have been captured in this analysis, these were the patients’ 
unprompted reasons for declining the service and this was an 
initial evaluation of reasons for declining the service.  
 
To have a full understanding of a patient’s health behaviors, a 
full comprehension of the patient’s perceptions regarding all 
elements of The Health Belief Model should be collected. 
Future evaluations would benefit from the development and 
administration of a survey using the complete Health Belief 
Model to better understand why patients accept and decline 
pharmacist-run appointments.  The other constructs of The 
Health Belief Model include perceived threat of conditions, 
belief in personal ability to handle one’s own health care, and 
triggers that might cause the patient to take action to improve 
their health.17 While this evaluation was not originally 
designed to evaluate all of these aspects, a full understanding 
of all elements of The Health Belief Model may help us to 
explain patient motivation in regards to clinical pharmacy 
services. Additionally, the impact of patient acceptance of 
pharmacist-run services from pharmacist role education, 
endorsements of the service by other members of the 
healthcare team, and bedside appointment scheduling should 
be evaluated. 
 
Conclusions 
This evaluation did not find a statistically significant difference 
in characteristics between those patients who accepted or 
declined participation in a pharmacist-run transition of care 
service. The primary reason for decline was no perceived 
benefit. To increase participation in pharmacist-run services, 
we need to understand the patient’s health beliefs and change 
the perception and understanding of pharmacist roles.  
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Figure 1: Patient Flow Diagram 
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Table 1: Descriptive Statistics 
 
Characteristics 
Total Patients 
(n=87) 
Declined 
(n=66) 
Accepted 
(n=21) 
P-Value 
Gender 
  Males, patients (%) 57 (65.5%) 44 (77.2%) 13(22.8%) 
0.79 
  Females, patients (%) 30 (34.5%) 22 (73.3%) 8 (26.7%) 
Geographic Location 
  Living in Green Bay/DePere, patients (%) 32 (36.8%) 23 (71.9%) 9 (28.1%) 
0.61 
  Living Outside, patients (%) 55 (63.2%) 43 (78.2%) 12 (21.8%) 
Mean Lace Score at Discharge, points (SD) 8.7 (2.4) 8.9 (2.4) 7.9 (2.1) 0.09 
  High Risk for Readmission  
[LACE≥10], patients (%) 26 (29.9%) 22 (84.7%) 4 (15.3%) 
0.29 
  Moderate Risk for Readmission  [LACE 5-9], patients (%) 61 (70.1%) 44 (72.1%) 17 (27.9%) 
Mean Age, years (SD) 66.4 (13.2) 65.7 (14.0) 68.80 (10.2) 0.53 
SD = Standard Deviation 
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Table 2: Logistic Regression of likelihood of accepting the service 
 
Characteristics Odds Ratio 95% CI P-Value 
Gender (M vs F) 0.81 0.28 2.37 0.70 
Location (GB/DP vs Outside) 1.30 0.46 3.69 0.62 
LACE Score at Discharge  
(Increase of 1 point) 0.79 0.61 1.02 0.065 
Age (Increase of 1 year) 1.03 0.98 1.07 0.22 
M vs F = Male versus Female; GB/DP = Green Bay/DePere  
 
